Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by Boomskidon Feb 22, 2023 11:26am
371 Views
Post# 35298378

Causing Implausible Speculation, With No Responsibilty

Causing Implausible Speculation, With No Responsibilty
Sometimes I think that poof posts something in the hope that readers will make assumptions that result in hype that poof, himself, will not post, possibly for legal reasons. It's a sly way of directing investor thought processes in a promotional direction while avoiding responsibility for their otherwise unsupportable conclusions.
 
But then, there's this. Notice that he's still pumping Midatech, Ladenburg Thalmann and Armistice. After Midatech's latest financing is complete, Midatech shareholders will see their ownership of Midatech move from 100% to as low as about 5%. If there is a similar Bioasis "financing" involving Ladenburg Thalmann, Armistice and Midatech, Bioasis shareholders could end up with 3% or less ownership of the resulting company. Further, in my opinion, it remains highly likely that the xB3 Platform and most of its potential commercial opportunities will be sold into private hands. It would likely wipe out any real potential for current Bioasis shareholders to have a win.
 
Poof makes posts that shed little light on anything. It's easy to snicker at his wild attempts to post something relevant and unique, but sometimes he posts something that makes me wonder if he's been told something by Bioasis. Does he then go on a Google treasure hunt for stuff that makes his posts have at least a whiff of considered and independent speculation about them?
 
There are people, both inside and outside of public companies, who allow false information and implausible speculation to go unchallenged because they don't care how investors come to the positive conclusion that higher share prices may be on the way. 
 
jd
 
<< Previous
Bullboard Posts
Next >>